JCLY News Alert Jaclyn Inc (JCLY) 5.6000 02/15/2015 00:25:21

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Jaclyn Inc (JCLY) 5.6000 $JCLY

Jaclyn EPS of $0.25
Seeking Alpha - at Seeking Alpha - Mon Jan 12, 11:03AM CST


Jaclyn Reports Third Quarter Financial Results
Marketwired - Mon Jan 12, 10:25AM CST
Jaclyn, Inc. (OTCQX: JCLY) today reported financial results for the third quarter ended November 30, 2014.

Jaclyn Reports Second Quarter Financial Results
Marketwired - Thu Oct 09, 11:36AM CDT
Jaclyn, Inc. (OTCQX: JCLY) today reported financial results for the second quarter ended August 31, 2014.

Jaclyn, Inc. Announces Amendment and Extension of Credit Facility
Marketwire - Wed Sep 24, 10:16AM CDT
Jaclyn, Inc. (OTCQX: JCLY) today announced that it has entered into an amendment and extension of its revolving credit facility with TD Bank, N.A., as Agent and a lender, and Israel Discount Bank of New York, as a lender. The term of the credit facility was extended until November 30, 2017. In addition, the maximum principal amount of revolving loans and face amount of letters of credit under the credit facility was set at $50,000,000; applicable interest rates were reduced to the prime rate less 0.25% or, at the Company's option, 200 basis points above a floating 30-day Libor rate, or a fixed Libor rate for interest periods of 1, 2, or 3 months; and the Company will no longer be required to pay a fee on the unused portion of the credit facility (previously 0.25% on the first $30,000,000 available under the credit facility). The Company's non-real estate assets are pledged to the bank as collateral. The credit facility continues to require the Company to maintain a specified minimum tangible net worth and interest coverage, as well as a debt to equity requirement, each measured annually.

Jaclyn Reports First Quarter Financial Results
Marketwire - Thu Jul 10, 2:10PM CDT
Jaclyn, Inc. (OTCQX: JCLY) today reported financial results for the first quarter ended May 31, 2014.




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Insights from the New First Presidency on Global Challenges

Updated Category News Views 218

A Historic Conversation with the First Presidency The recent interview featuring the new First Presidency of The Church of Jesus Christ of Latter-day Saints marks an exciting milestone. Conducted by the talented Jane Clayson Johnson, this unique dialogue sheds light on pressing issues within the Church and broader society. It was their first public discussion, making it a...

Continue Reading
Major Bets on Donald Trump's Election Surge Past $52 Million

Updated Category News Views 119

Significant Bets on Trump's Electoral Success A trader on Polymarket, operating under the alias Fredi9999, alongside four other accounts, has made headlines recently by placing enormous bets on Donald Trump’s electoral prospects. This activity has generated considerable chatter among traders in the market. Tracking Trump's Betting Activity Harry Crane, a statistics...

Continue Reading
FMC Corporation Faces Lawsuit Over Securities Violations

Updated Category News Views 190

FMC Corporation Faces Lawsuit Over Securities Violations Recently, the Gross Law Firm has alerted shareholders of FMC Corporation (NYSE: FMC) regarding significant legal developments. This lawsuit brings attention to serious allegations concerning the company's conduct during a specific class period. Shareholder Engagement and Participation Shareholders who purchased FMC...

Continue Reading
Insider Buying at Optima Health Signals Confidence in Future Growth

Updated Category News Views 132

Insightful Insider Share Purchase at Optima Health Optima Health plc (AIM: OPT), a leading provider of corporate health and wellbeing solutions in the UK, recently announced an important transaction involving one of its key insiders. Joanne Newey, who takes on the role of Group Business Development & Propositions Director and is also a Person Discharging Managerial...

Continue Reading
Outlook Therapeutics Prepares for Upcoming Investor Interaction

Updated Category News Views 78

Outlook Therapeutics Connects with Investors at Upcoming Virtual Event ISELIN, N.J. — Outlook Therapeutics, Inc. (Nasdaq: OTLK) has been making waves in the biopharmaceutical field with its groundbreaking ocular therapy. This marks an exciting era for the company following the recent approval of its eye treatment formulation of bevacizumab, which targets wet age-related...

Continue Reading